Trials / Completed
CompletedNCT06032260
The Effects of a Fiber-enriched Bakery Product on Glucose, Insulin Values and Appetite
The Effects of a Fiber-enriched Bakery Product on Glucose, Insulin Values and Appetite. A Pilot Randomized Cross-over Trial
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 10 (actual)
- Sponsor
- University of Turin, Italy · Academic / Other
- Sex
- All
- Age
- 20 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
The aim of the present pilot randomized controlled trial is to compare the effects of the following: 1)-panettone enriched with arabinoxylans (p-rich), 2)-panettone not enriched (p-standard) on blood glucose and insulin values, and appetite scores in 10 healthy volunteers.
Detailed description
This is a crossover, randomized double-blind trial. A product enriched with arabinoxylan extracted from threshing (panettone, p-rich, a sweet baked product with a high glycemic index) was developed to assess the impact on metabolic responses and satiety when compared to the standard product (p-standard) . Ten Caucasian non-smoker healthy adult volunteers were enrolled starting from January 2023. Participants were randomized to receive either the p-rich or p-standard. The order of administration of each product was randomized using a computer-generated sequence. The day of each test, fasting individuals underwent a blood sample collection, and weight and height measurements. Then, participants consumed 100 grams of the product within 20 minutes, while sitting. Blood samples were collected at 15, 30, 45, 60, 90, 120 minutes after the consumption of each food.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Enriched panettone | Volunteers consumed 100 grams of panettone enriched with fiber (JAX Plus® (Heallo srl, Milano, Italy), a soluble fiber with Arabinoxylans from wheat and barley |
| OTHER | Panettone standard | Volunteers consumed 100 grams of panettone standard |
Timeline
- Start date
- 2023-01-20
- Primary completion
- 2023-06-30
- Completion
- 2023-07-30
- First posted
- 2023-09-11
- Last updated
- 2023-09-13
Locations
1 site across 1 country: Italy
Source: ClinicalTrials.gov record NCT06032260. Inclusion in this directory is not an endorsement.